Dr. Reddy’s Laboratories Ltd. ADR (NYSE:RDY) does about 2.12M shares in volume on a normal day but saw 1690706 shares change hands in the recent trading day. The company now has a market cap of 13.15B USD. Its current market price is $15.80, marking a decrease of -2.29% compared to the previous close of $16.17. The 52 week high reached by this stock is $16.89 whilst the lowest price level in 52 weeks is $12.26.
The consensus objective for the share price is $14.75, suggesting that the stock has a potential downside of -7.12% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on June 05, 2025 when HSBC Securities upgraded the stock to “Buy” and issued a price target of $16.90.
The current price level is 5.40%, 11.94%, and 8.73% away from its SMA20, SMA50, and SMA200 respectively, with the RDY price moving above the 50-day SMA on current market day. Dr. Reddy’s Laboratories Ltd. ADR (RDY) stock is up 1.61% over the week and 11.74% over the past month. Its price is 0.06% year-to-date and 9.69% over the past year.
To reach the target analysts have set, the stock logically needs to shrink -7.12 percent from here.
Outstanding shares total 834.46M with insiders holding 0.00% of the shares and institutional holders owning 13.85% of the company’s common stock. The company has a return on investment of 16.71% and return on equity of 18.36%. The price to earnings ratio (P/E ratio) amounts to 19.73 while the forward price to earnings ratio is 24.44. The beta has a value of 0.33. Price to book ratio is 3.38 and price to sales ratio is 3.41.
